Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation

Journal of Immunology

Volumn 178, Issue 7, 2007, Pages 4615-4622

  Boniface, Katia ^a   Diveu, Caroline ^b,g   Morel, Franck ^a   Pedretti, Nathalie ^c   Froger, Josy ^b,g   Ravon, Elisa ^b,g   Garcia, Martine ^a   Venereau, Emilie ^b,g   Preisser, Laurence ^b,g   Guignouard, Emmanuel ^a   Guillet, Gérard ^a,d   Dagregorio, Guy ^a,d   Pène, Jérôme ^e   Moles, Jean Pierre ^f   Yssel, Hans ^e   Chevalier, Sylvie ^b,g   Bernard, François Xavier ^c   Gascan, Hugues ^b,g   Lecron, Jean Claude ^a  

^a UNIVERSITÉ DE POITIERS   (France)

^b INSERM   (France)

^c BIOalternatives   (France)

^d Centre Hospitalier de l'Université la Milétrie   (France)

^e HÔPITAL ARNAUD DE VILLENEUVE   (France)

^f UNIV MONTPELLIER   (France)

^g UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 22; MITOGEN ACTIVATED PROTEIN KINASE; ONCOSTATIN M; PSORIASIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PSORIASIS; SKIN INFLAMMATION; T LYMPHOCYTE;

EID: 33947671498     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.7.4615     Document Type: Article

References (42)

1. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279.
2. Christophers, E., and T. Henseler. 1987. Contrasting disease patterns in psoriasis and atopic dermatitis. Arch. Dermatol. Res. 279: S48-S51.
3. Nomura, I., E. Goleva, M. D. Howell, Q. A. Hamid, P. Y. Ong, C. F. Hall, M. A. Darst, B. Gao, M. Boguniewicz, J. B. Travers, and D. Y. Leung. 2003. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol. 171: 3262-3269.
4. Richards, C. D., T. J. Brown, M. Shoyab, H. Baumann, and J. Gauldie. 1992. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J. Immunol. 148: 1731-1736.
5. Kamiya, A., T. Kinoshita, Y. Ko, T. Matsui, Y. Morikawa, E. Senba, K. Nakashima, T. Taga, K. Yoshida, T. Kishimoto, and A. Miyajima. 1999. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J. 18: 2127-2136.
6. Gearing, D. P., C. J. Thut, T. VandeBos, S. D. Gimpel, P. B. Delaney, J. King, V. Price, D. Cosman, and M. P. Beckmann. 1991. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 10: 2839-2848.
7. Gearing, D. P., M. R. Comeau, D. J. Friend, S. D. Gimpel, C. J. Thut, J. McGourty, K. K. Brasher, J. A. King, S. Gillis, and B. Mosley. 1992. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255: 1434-1437.
8. Mosley, B., C. De Imus, D. Friend, N. Boiani, B. Thoma, L. S. Park, and D. Cosman. 1996. Dual oncostatin M (OSM) receptors: cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem. 271: 32635-32643.
9. Ishihara, K., and T. Hirano. 2002. Molecular basis of the cell specificity of cytokine action. Biochim. Biophys. Acta. 1592: 281-296.
10. Dillon, S. R., C. Sprecher, A. Hammond, J. Bilsborough, M. Rosenfeld-Franklin, S. R. Presnell, H. S. Haugen, M. Maurer, B. Harder, J. Johnston, et al. 2004. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 5: 752-760.
11. Bernard, F. X., N. Pedretti, M. Rosdy, and A. Deguercy. 2002. Comparison of gene expression profiles in human keratinocyte mono-layer cultures, reconstituted epidermis and normal human skin; transcriptional effects of retinoid treatments in reconstituted human epidermis. Exp. Dermatol. 11: 59-74.
12. Boniface, K., F. X. Bernard, M. Garcia, A. L. Gurney, J. C. Lecron, and F. Morel. 2005. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174: 3695-3702.
13. Sano, S., S. Itami, K. Takeda, M. Tarutani, Y. Yamaguchi, H. Miura, K. Yoshikawa, S. Akira, and J. Takeda. 1999. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 18: 4657-4668.
14. Rosdy, M., B. Bertino, V. Butet, S. Gibbs, M. Ponec, and M. Darmon. 1997. Retinoic acid inhibits epidermal differentiation when applied topically on the stratum corneum of epidermis formed in vitro by human keratinocytes grown on defined medium. In Vitro Toxicol. 10: 39-47.
15. Yssel, H., and H. Spits. 2001. In vitro culture of subpopulations of human T lymphocytes. In Current Protocols in Immunology, Green & Wiley, New York. 7-19.
16. Trickett, A., and Y. L. Kwan. 2003. T cell stimulation and expansion using anti-CD3/CD28 beads. J. Immunol. Methods 275: 251-255.
17. Boniface, K., J. C. Lecron, F. X. Bernard, G. Dagregorio, G. Guillet, F. Nau, and F. Morel. 2005. Keratinocytes as targets for interleukin-10-related cytokines: a putative role in the pathogenesis of psoriasis. Eur. Cytokine Network 16: 309-319.
18. Diveu, C., A. H. Lak-Hal, J. Froger, E. Ravon, L. Grimaud, F. Barbier, J. Hermann, H. Gascan, and S. Chevalier. 2004. Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling. Eur. Cytokine Network 15: 291-302.
19. Thoma, B., T. A. Bird, D. J. Friend, D. P. Gearing, and S. K. Dower. 1994. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J. Biol. Chem. 269: 6215-6222.
20. Lew, W., A. M. Bowcock, and J. G. Krueger. 2004. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and 'Type 1' inflammatory gene expression. Trends Immunol. 25: 295-305.
21. Finelt, N., A. Gazel, S. Gorelick, and M. Blumenberg. 2005. Transcriptional responses of human epidermal keratinocytes to oncostatin-M. Cytokine 31: 305-313.
22. Auguste, P., C. Guillet, M. Fourcin, C. Olivier, J. Veziers, A. Pouplard-Barthelaix, and H. Gascan. 1997. Signaling of type II oncostatin M receptor. J. Biol. Chem. 272: 15760-15764.
23. Sano, S., K. S. Chan, S. Carbajal, J. Clifford, M. Peavey, K. Kiguchi, S. Itami, B. J. Nickoloff, and J. DiGiovanni. 2005. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 11: 43-49.
24. Gazel, A., M. Rosdy, B. Bertino, C. Tornier, F. Sahuc, and M. Blumenberg. 2006. A characteristic subset of psoriasis-associated genes is induced by oncostatin-M in reconstituted epidermis. J. Invest. Dermatol. 126: 2647-2657.
25. Roth, J., T. Vogl, C. Sorg, and C. Sunderkotter. 2003. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 24: 155-158.
26. Broome, A. M., D. Ryan, and R. L. Eckert. 2003. S100 protein subcellular localization during epidermal differentiation and psoriasis. J. Histochem. Cytochem. 51: 675-685.
27. Sugiura, H., H. Ebise, T. Tazawa, K. Tanaka, Y. Sugiura, M. Uehara, K. Kikuchi, and T. Kimura. 2005. Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope. Br. J. Dermatol. 152: 146-149.
28. Ryckman, C., K. Vandal, P. Rouleau, M. Talbot, and P. A. Tessier. 2003. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 170: 3233-3242.
29. Yoshimura, T., K. Matsushima, S. Tanaka, E. A. Robinson, E. Appella, J. J. Oppenheim, and E. J. Leonard. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 84: 9233-9237.
30. Wuyts, A., P. Proost, J. P. Lenaerts, A. Ben-Baruch, J. Van Damme, and J. M. Wang. 1998. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. Eur. J. Biochem. 255: 67-73.
31. Koch, A. E., S. L. Kunkel, L. A. Harlow, D. D. Mazarakis, G. K. Haines, M. D. Burdick, R. M. Pope, A. Walz, and R. M. Strieter. 1994. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J. Clin. Invest. 94: 1012-1018.
32. Nickoloff, B. J. 2001. Creation of psoriatic plaques: the ultimate tumor suppressor pathway: a new model for an ancient T-cell-mediated skin disease. J. Cutan. Pathol. 28: 57-64.
33. Gallo, R. L., M. Murakami, T. Ohtake, and M. Zaiou. 2002. Biology and clinical relevance of naturally occurring antimicrobial peptides. J. Allergy Clin. Immunol. 110: 823-831.
34. Nizet, V., T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R. A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, and R. L. Gallo. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457.
35. Glaser, R., J. Harder, H. Lange, J. Bartels, E. Christophers, and J. M. Schroder. 2005. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat. Immunol. 6: 57-64.
36. Harder, J., J. Bartels, E. Christophers, and J. M. Schroder. 1997. A peptide antibiotic from human skin. Nature 387: 861-861.
37. Harder, J., and J. M. Schroder. 2005. Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J. Leukocyte Biol. 77: 476-486.
38. Howell, M. D., N. Novak, T. Bieber, S. Pastore, G. Girolomoni, M. Boguniewicz, J. Streib, C. Wong, R. L. Gallo, and D. Y. Leung. 2005. Interleukin-10 down-regulates anti-microbial peptide expression in atopic dermatitis. J. Invest. Dermatol. 125: 738-745.
39. Gearing, A. J., N. J. Fincham, C. R. Bird, M. Wadhwa, A. Meager, J. E. Cartwright, and R. D. Camp. 1990. Cytokines in skin lesions of psoriasis. Cytokine 2: 68-75.
40. Grossman, R. M., J. Krueger, D. Yourish, A. Granelli-Piperno, D. P. Murphy, L. T. May, T. S. Kupper, P. B. Sehgal, and A. B. Gottlieb. 1989. Imerleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. USA 86: 6367-6371.
41. Murphy, J. E., C. Robert, and T. S. Kupper. 2000. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J. Invest. Dermatol. 114: 602-608.
42. Teunissen, M. B., C. W. Koomen, R. de Waal Malefyt, E. A. Wierenga, and J. D. Bos. 1998. Interleukin-17 and Interferon-γ synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol. 111: 645-649.